The H69V and H1184 cell lines were used to assess the possible role of KEAP1 silencing in SCLC resistance to chemotherapy treatment, using cisplatin and etoposide treatments alone and in combination. The gene discussed is KEAP1; the disease is small cell lung carcinoma.